Open AccessIntegration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative
Author(s) -
Linda Weiss,
Julie Netherland,
James E. Egan,
Timothy P. Flanigan,
David A. Fiellin,
Ruth Finkelstein,
Frederick L. Altice
Publication year - 2011
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e31820a8226
Subject(s) - buprenorphine , staffing , medicine , nursing , (+) naloxone , mental health , human immunodeficiency virus (hiv) , clinical supervision , integrated care , health care , family medicine , psychiatry , opioid , receptor , economics , economic growth
Replication of effective practices requires detailed descriptions of implementation processes, barriers and facilitators, and lessons learned. The experiences of physicians leading the Buprenorphine HIV Evaluation and Support initiative provides valuable information for other HIV providers seeking to integrate medication-assisted treatment services into HIV clinical care.